STME
Stimcell Energetics, Inc.0.3684
-0.0425-10.4%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
7.60MP/E (TTM)
-Basic EPS (TTM)
-0.04Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
eBalance® mitochondrial study launched
StimCell Energetics signed a service agreement, effective December 1, 2025, with St. Boniface Hospital Albrechtsen Research Centre to study its eBalance® device's effects on mitochondrial function in cultured sensory neurons. The three-month project measures oxygen consumption rates, ATP production, and enzyme activities in rat DRG neurons. Study sharpens microcurrent mechanism. CEO hails mitochondrial performance potential, amid forward-looking risks.
10-Q
Q1 FY2026 results
Stimcell Energetics posted a Q1 FY2026 net loss of $265,602 for the quarter ended August 31, 2025, up from $66,919 y/y, driven by $57,309 in new R&D on eBalance redesign with ADM Tronics and $120,000 non-cash investor relations shares; general/admin expenses jumped to $139,484 from $16,451 y/y. Operating loss matched net loss closely, with interest at $13,248. Cash dwindled to $6,437 after $108,142 ops burn, offset by $100,000 related-party note at 10%; total related debt hit $582,013, some in default. No revenue yet. Cash funds R&D runway.
10-K
FY2025 results
Stimcell Energetics posted FY2025 net loss of $566k, up from $142k last year, on $522k operating expenses—94.6% higher—while revenue stayed at zero. Q4 saw R&D surge to $64k total as February partnership with ADM Tronics kicked off eBalance redesign, ending prior suspension. Cash dwindled to $15k amid $142k operating burn, offset by $113k related-party loans at 10%. Working capital deficit hit $1.2M. No quarterly breakdowns disclosed. Going concern in doubt. Heavy related-party reliance risks funding shortfalls.
BSEM
BioStem Technologies, Inc.
3.84-0.11
BWAY
Brainsway Ltd.
16.87-0.47
CBLL
CeriBell, Inc.
21.99+0.09
CVRX
CVRx, Inc.
8.32+0.14
EBRCZ
EBR SYSTEMS INC NPV CDI 1:1
0.60+0.00
ECOR
electroCore, Inc.
4.79+0.02
EMED
Electromedical Technologies, In
0.00+0.00
ENDV
Endonovo Therapeutics, Inc.
0.00+0.00
NMTC
NeuroOne Medical Technologies C
0.71+0.05
STIM
Neuronetics, Inc.
1.65-0.11